Market Access News | pharmaphorum

News

FDA clears Roche digital pathology platform for diagnosis

Roche’s move into the digital pathology category has been boosted by FDA approval of a lab instrument and toolkit for use as an aid to clinical diagnosis.

News

FDA says yes to MSD’s 21-valent adult pneumococcal jab

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults.

News

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

News

SCOTUS rejects challenge to abortion pill mifepristone

The Supreme Court has rejected a lawsuit challenging the authority of the FDA to regulate the abortion pill mifepristone, in a move that will ensure it can still be provided by mail-order w

News

WuXi buoyed as BIOSECURE Act is left out of US spending bill

Shares in WuXi Biologics and WuXi AppTec have tracked up after the BIOSECURE Act – which could have profound effects on their businesses in the US – was omitted from legislation due to be f

News

Mahana’s DTx for IBS gets permanent reimbursement in Germany

Mahana Therapeutics has been granted permanent reimbursement in Germany for its Cara Care for irritable bowel syndrome (IBS), paving the way for greater patient access to the digital therap

FDA clears Roche digital pathology platform for diagnosis

FDA says yes to MSD’s 21-valent adult pneumococcal jab

FDA widens label for BMS’ cancer drug Augtyro

SCOTUS rejects challenge to abortion pill mifepristone

WuXi buoyed as BIOSECURE Act is left out of US spending bill

Mahana’s DTx for IBS gets permanent reimbursement in Germany

Amgen's Imdelltra scores again in small cell lung cancer

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks